2023
DOI: 10.1038/s41598-023-29510-2
|View full text |Cite
|
Sign up to set email alerts
|

Comparison of the quality of life of patients with liver cirrhosis before and during the COVID-19 lockdown in Slovakia

Abstract: Liver cirrhosis is associated with a poor quality of life (QOL). The COVID-19 pandemic has led to several restriction measures and psychosocial consequences whose impact on QOL has combined with that of cirrhosis in an unknown way. Therefore, we have used our cirrhosis registry to assess the quality of life before the pandemic (on the first admission to the tertiary liver unit) and during the most pronounced phase of the first lockdown. In this cross-sectional study conducted during the first lockdown in Slova… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 49 publications
0
1
0
Order By: Relevance
“…Finally, EQ-5D is advocated and recommended by the health technology assessment national agency, which is beneficial in close connection with participants' survival status, sufficient sensitivity to detect deteriorated health status, and usage to facilitate healthcare decision-making. 12 Previous studies have used EQ-5D to evaluate HRQoL in various liver diseases; [13][14][15][16] however, there is a lack of an outcome-based threshold to stratify patients with cirrhosis into distinct risk groups. Identification of such threshold may shed light on comparison between different diseases regarding relative impact, accurate appraisal of influencing HRQoL domain and precision medicine tailored to individual patient's needs.…”
Section: Introductionmentioning
confidence: 99%
“…Finally, EQ-5D is advocated and recommended by the health technology assessment national agency, which is beneficial in close connection with participants' survival status, sufficient sensitivity to detect deteriorated health status, and usage to facilitate healthcare decision-making. 12 Previous studies have used EQ-5D to evaluate HRQoL in various liver diseases; [13][14][15][16] however, there is a lack of an outcome-based threshold to stratify patients with cirrhosis into distinct risk groups. Identification of such threshold may shed light on comparison between different diseases regarding relative impact, accurate appraisal of influencing HRQoL domain and precision medicine tailored to individual patient's needs.…”
Section: Introductionmentioning
confidence: 99%